Performance of different clinical trial designs to evaluate treatments during an epidemic
In the 2013-2016 west Africa outbreak of Ebola Virus Disease (EVD), most of the planned clinical trials failed to reach a conclusion within the time frame of the epidemic. The performance of clinical trial designs for the evaluation of one or more experimental treatments in the specific context of a...
Main Authors: | Brueckner, M, Titman, A, Jaki, T, Rojek, A, Horby, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2018
|
Similar Items
-
Modernising epidemic science: enabling patient-centred research during epidemics
by: Rojek, A, et al.
Published: (2016) -
Regulatory and operational complexities of conducting a clinical treatment trial during an Ebola Virus Disease epidemic
by: Rojek, A, et al.
Published: (2017) -
Insights from clinical research completed during the west Africa Ebola virus disease epidemic
by: Rojek, A, et al.
Published: (2017) -
Core minimal datasets to advance clinical research for priority epidemic diseases
by: Rojek, AM, et al.
Published: (2019) -
Offering patients more: how the West Africa Ebola outbreak can shape innovation in therapeutic research for emerging and epidemic infections
by: Rojek, A, et al.
Published: (2017)